Cagent Vascular Announces CE Mark of Serranator, Next Generation Device for Vessel Dilatation in Peripheral Artery Disease Interventions

Serranator[R] has achieved regulatory approvals from both FDA and European Medicines Agency, paving way for successful commercialization WAYNE, Pa. -- Cagent Vascular, a developer of next generation technology for vessel [...]